1. Resposta sorológica de ovinos inoculados com plasmídeos codificando a glicoproteína D do herpesvírus bovino 1 (BHV-1)
- Author
-
Rômulo Cerqueira Leite, Luciana Regina Guimarães Bessa, Alexandre Luna Cândido, and Mauricio G. C. Resende
- Subjects
DNA vaccine ,glycoprotein D gene ,animal diseases ,viruses ,Congenital cytomegalovirus infection ,Heterologous ,Vacina de DNA ,SF1-1100 ,Serology ,Ovinos ,bovine herpesvirus-1.2a ,Plasmid ,Antigen ,medicine ,Teste ELISA ,lcsh:SF1-1100 ,chemistry.chemical_classification ,General Veterinary ,biology ,Herpesvirus bovino ,virus diseases ,biochemical phenomena, metabolism, and nutrition ,medicine.disease ,biology.organism_classification ,Virology ,Molecular biology ,Bovine herpesvirus 1 ,Animal culture ,chemistry ,biology.protein ,ELISA ,lcsh:Animal culture ,Vacinas veterinárias ,Antibody ,Glycoprotein - Abstract
A genetic vaccine consisting of the bovine herpesvirus-1.2a (BHV-1.2a) glycoprotein D (gD) gene under the control of the cytomegalovirus immediate-early promoter/enhancer was generated and administered to sheep intramuscularly in the neck. All animals developed serum antibodies which recognized the homologous antigen (BHV-1.2a strain BH-83) and also exhibited cross-reactivity against the heterologous antigen (BHV-5 strain EVI-190). Three intramuscularly injections were given but serological responses were not improved after the second inoculation. Specific antibodies were detected against BHV-1.2a until at least 12 months after the first inoculation. However, the capacity to induce antibodies against BHV-5 was lower and of shorter duration than to BHV-1.2a. _________________________________________________________________________________________ ABSTRACT: Uma vacina geneticamente preparada com o gene da glicoproteína D do herpesvirus bovino-1.2a (BHV-1.2a) controlado com o promotor/potenciador imediatamente precoce de citomegalovírus foi administrada no pescoço de ovinos. Todos os animais produziram anticorpos séricos que reconheceram, em ELISA, o antígeno homólogo (BHV-1.2a, amostra BH-83) e também mostraram reatividade cruzada contra um antígeno heterólogo (BHV-5 amostra EVI-190). Foram aplicadas três inoculações, mas não houve melhora de resposta com a terceira inoculação. Resposta específica contra BHV-1.2a foi detectada pelo menos até 12 meses após a primeira inoculação, entretanto, a resposta sorológica contra o BHV-5 foi de menor intensidade e duração do que aquela contra o BHV-1.2a.
- Published
- 2003